A phase II study of the pineal hormones melatonin and 5-methoxytryptamine plus cannabidiol in association with angiotensin 1-7 in the treatment of advanced solid tumour patients eligible for the only best supportive care
Abstract: The recent advances in the investigation of tumour biology have demonstrated that the human body may produce several molecules provided by a natural anticancer activity without any toxicity, in particular the pineal hormones melatonin (MLT), 5-methoxytryptamine (5-MTT) and pinealine, the...
Guardado en:
| Autores principales: | Lissoni, Paolo, Porro, Giorgio, Messina, Giusy, Galli, Carla, Di Fede, Giuseppe, Valentini, Agnese, Simoes-e-Silva, Ana Cristina, Cardinali, Daniel Pedro |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Lupin
2022
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/13686 |
| Aporte de: |
Ejemplares similares
-
A randomized study of high-dose pineal hormone melatonin alone versus high-dose melatonin plus low-dose angiotensin-(1-7) in untreatable advanced cancer patients
por: Lissoni, Paolo, et al.
Publicado: (2022) -
A preliminary study of low-dose angiotensin 1-7 plus the pineal hormone melatonin in the treatment of human systemic diseases other than cancer and autoimmune pathologies
por: Lissoni, Paolo, et al.
Publicado: (2022) -
Psycho Neuroendocrino Immune (PNEI) therapy of cancer beyond melatonin
por: Lissoni, Paolo, et al.
Publicado: (2022) -
Angiotensin converting enzyme inhibitors : mechanisms of action and clinical implications /
Publicado: (1981) -
Angiotensin-converting enzyme 2: angel or evil?
por: Gironacci, Mariela M.
Publicado: (2021)